Targeted Cancer Therapies
Olaparib
BPT-1208 · Capsule & tablet
What is it used for?
Blocks PARP, an enzyme involved in DNA repair. Used in specified ovarian, breast, pancreatic and prostate cancer settings; BRCA or other biomarkers, prior treatment and combinations determine eligibility. Bile-duct cancer is not an FDA-labeled indication. Capsules and tablets are not interchangeable on a milligram-for-milligram basis.
- Dosage form
- Capsule & tablet
- Listed strengths
- 50 mg & 150 mg
- Listed pack size
- 112's & 120's
- Mechanism
- PARP inhibitor
Specifications supplied in the Everest product list; formulation, pack configuration, availability and local authorization require confirmation. These medicines are not for self-medication.
Clinical use overview
- Selected ovarian, breast, pancreatic and prostate cancers
Important information
Educational information about the active ingredient, not a treatment recommendation or a claim that Beptide's presentation is approved. Approved uses differ by country and product. Cancer medicines require specialist assessment; biomarkers, stage, previous treatments and combinations can determine eligibility.
FDA prescribing information
